Monsanto wheat patent disputed

Greenpeace, Indian groups challenge company's rights to strain known as Nap Hal

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Greenpeace is challenging patent rights to a wheat strain granted to Monsanto, the world's largest genetically modified (GM) seed company, on grounds of “biopiracy.” The dispute continues the environmental group's demands against patenting of any plants, animals, humans, and genes.

Greenpeace says the patented variety of wheat possesses genetic characteristics originally derived from a strain known as Nap Hal used to make chapatis, the flat bread traditional to northern India.

“Monsanto is trying to get ownership of the specific genetic traits of Nap Hal,” Greenpeace Genetic Engineering Campaigner Christoph Then told The Scientist. “It's robbery of generations of effort in cultivation of Indian farmers.”

The company vigorously denied the allegations. “The people opposing the patent allege there's nothing novel here. But it is indeed a novel invention,” Monsanto Europe–Africa's Director of Public Affairs Thomas McDermott said. “The patent has been granted, and we will defend it.”

Nap Hal has less ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Charles Choi

    This person does not yet have a bio.
Share
Image of people clinking glasses with various alcoholic beverages at a table.
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
An illustration of colorful shapes.

Real-Time Image-Enabled Cell Sorting 

BD
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
Wastewater surveillance conceptual visualization of a water droplet containing different microorganism

Elevating Wastewater Epidemiology with Microfluidics

Products

Takara Bio

Takara Bio USA Holdings, Inc. announces the acquisition of Curio Bioscience, adding spatial biology to its broad portfolio of single-cell omics solutions

Sapio Sciences

Sapio Sciences Announces Enhanced Capabilities for Chemistry, Immunogenicity, GMP and Molecular Biology

Biotium Logo

Biotium Unveils the Most Sensitive Stains for DNA or RNA with New EMBER™ Ultra Agarose Gel Kits

Cytosurge Logo

Cytosurge Announces Strategic Leadership Transition